Breaking News Instant updates and real-time market news.

ON

ON Semiconductor

$21.00

-0.36 (-1.69%)

, TXN

Texas Instruments

$109.93

-0.22 (-0.20%)

05:58
08/14/18
08/14
05:58
08/14/18
05:58

ON Semiconductor pullback a buying opportunity, says Mizuho

Mizuho analyst Vijay Rakesh views the recent pullback in shares of ON Semiconductor (ON) as a buying opportunity. The analyst attributes the selloff to concerns of a peaking semi cycle, but points out that over the last four-years, ON's exposure to auto and industrial revenue has almost doubled. However, the stock trades at a 50% discount to automotive and industrial peers including Texas Instruments (TXN), NXP Semiconductors (NXPI), Analog Devices (ADI), Maxim Integrated (MXIM) and Monolithic Power (MPWR), Rakesh tells investors in a research note.

ON

ON Semiconductor

$21.00

-0.36 (-1.69%)

TXN

Texas Instruments

$109.93

-0.22 (-0.20%)

NXPI

NXP Semiconductors

$93.13

-1.44 (-1.52%)

ADI

Analog Devices

$95.13

0.18 (0.19%)

MXIM

Maxim Integrated

$61.41

0.02 (0.03%)

MPWR

Monolithic Power

$139.83

0.22 (0.16%)

  • 14

    Aug

  • 14

    Aug

  • 16

    Aug

  • 22

    Aug

  • 11

    Sep

  • 12

    Sep

  • 08

    May

ON ON Semiconductor
$21.00

-0.36 (-1.69%)

08/09/18
08/09/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GOLDMAN CUTS SEAGATE TO SELL: Goldman Sachs analyst Mark Delaney downgraded Seagate Technology (STX) to Sell from Neutral and lowered his price target for the shares to $44 from $50, representing 20% downside from current levels. While Seagate has improved its product offerings in the last few years, hard disk drives remain a cyclical industry, and one "facing secular challenges in many parts of the market," Delaney said. He believes Seagate's fundamentals will peak in the second half of 2018 and decline in 2019. RBC CUTS FOX TO SECTOR PERFORM ON VALUATION: RBC Capital analyst Steven Cahall downgraded 21st Century Fox (FOXA) to Sector Perform from Outperform, but raised his price target to $49 from $45. The analyst noted that the stock is now trading near its M&A price and that he does not see any competitive bids emerging. Cahall adds that while the company is "undervalued", he awaits the separation to re-evaluate his stance. MORGAN STANLEY DOWNGRADES SEMI INDUSTRY: Morgan Stanley analyst Joseph Moore said he has become less constructive on semiconductor stocks through the year and he now believes elevated inventory levels and stretched lead times leave "no margin for error." Given his view that any lead time adjustment or demand slowdown could drive a "meaningful correction," Moore has downgraded his semiconductor industry view to Cautious from In-Line. He favors connector companies, like Amphenol (APH) and TE Connectivity (TEL) over analog/MCU at this point in the cycle, due to lower risk around lead time issues, Moore said. He also has a "strong preference" for high margin and more defensive models, such as Analog Devices (ADI) over lower margin and commodity exposed ones, like Cypress Semiconductor (CY) and ON Semiconductor (ON), he said. Despite his more cautious view on the space, Moore kept Overweight ratings on Nvidia (NVDA), Xilinx (XLNX) and Ambarella (AMBA), citing his view that they should benefit from secular growth in the area of AI, data center, and autonomous. SOUTHERN COMPANY GETS MULTIPLE DOWNGRADES AFTER Q2 REPORT: Barclays analyst Eric Beaumont downgraded Southern Company (SO) to Equal Weight and lowered his price target for the shares to $48 from $51. Credit Suisse analyst Michael Weinstein downgraded Southern Company to Underperform from Neutral and lowered his price target on the shares to $43 from $46. Guggenheim analyst Shahriar Pourreza downgraded Southern Company to Neutral from Buy and lowered his price target on the stock to $47 from $50. Evercore ISI analyst Greg Gordon downgraded Southern Company to Underperform from In Line and lowered his price target on Southern shares to $46 from $46.75.
08/09/18
MSCO
08/09/18
DOWNGRADE
MSCO
Underweight
ON Semiconductor downgraded to Underweight from Equal Weight at Morgan Stanley
08/09/18
MSCO
08/09/18
NO CHANGE
MSCO
Morgan Stanley downgrades semiconductor industry view to Cautious
Morgan Stanley analyst Joseph Moore said he has become less constructive on semiconductor stocks through the year and he now believes elevated inventory levels and stretched lead times leave "no margin for error." Given his view that any lead time adjustment or demand slowdown could drive a "meaningful correction," Moore has downgraded his semiconductor industry view to Cautious from In-Line. He favors connector companies, like Amphenol (APH) and TE Connectivity (TEL) over analog/MCU at this point in the cycle, due to lower risk around lead time issues, Moore said. He also has a "strong preference" for high margin and more defensive models, such as Analog Devices (ADI) over lower margin and commodity exposed ones, like Cypress Semiconductor (CY) and ON Semiconductor (ON), he said. Despite his more cautious view on the space, Moore keeps Overweight ratings on Nvidia (NVDA), Xilinx (XLNX) and Ambarella (AMBA), citing his view that they should benefit from secular growth in the area of AI, data center, and autonomous. Other semiconductor names include Microchip (MCHP), Qorvo (QRVO), Micron (MU), Intel (INTC), Broadcom (AVGO) and Qualcomm (QCOM).
08/09/18
MSCO
08/09/18
DOWNGRADE
Target $18.5
MSCO
Underweight
ON Semiconductor downgraded to Underweight on cyclical risks at Morgan Stanley
As previously reported, Morgan Stanley analyst Craig Hettenbach downgraded ON Semiconductor to Underweight from Equal Weight as he see a reduction in lead times serving as a possible catalyst for an inventory correction by Q4. He also views ON Semi shares as more susceptible to multiple contraction than peers if the cycle turns given the stock's period of strong outperformance. Hettenbach lowered his price target on ON Semi shares to $18.50 from $20.
TXN Texas Instruments
$109.93

-0.22 (-0.20%)

07/31/18
LOOP
07/31/18
NO CHANGE
Target $70
LOOP
Buy
Texas Instruments to generate above-consensus revenue, says Loop Capital
Loop Capital analyst Ananda Baruah kept his Buy rating and $70 price target on Texas Instruments, saying the company should continue tracking with stronger than expected revenue, earnings, and gross margins. The analyst notes that while the current quarter is less favorable than the prior one, the revenue mix will improve amid the ramp in demand for Cloud drives "through at least 2019", the increase in demand for Edge applications such as video surveillance, and the start of ramp of Enterprise SSDs using NAND memory.
07/25/18
JEFF
07/25/18
NO CHANGE
Target $157
JEFF
Buy
Texas Instruments price target raised to $157 from $150 at Jefferies
Jefferies analyst Mark Lipacis raised his price target for Texas Instruments to $157 saying his conviction is increased following last night's Q2 results. The Street is underestimating the company's revenue growth and margin potential, Lipacis tells investors in a research note. He believes Texas Instruments' operating margins will expand another 1,000 basis points over the next 3-to-5 years to 50%. Lipacis reiterates a Buy rating on the shares.
07/25/18
JPMS
07/25/18
NO CHANGE
Target $134
JPMS
Overweight
Texas Instruments target raised to $134 on 'strong' Q2 at JPMorgan
JPMorgan analyst Harlan Sur raised his price target for Texas Instruments to $134 from $132 saying the company last night reported "another strong" quarter on continued Auto/Industrial strength and broad-based growth across geographies. The analyst believes macro demand trends remain healthy and that supply side metrics are at normal/stable levels. He keeps an Overweight rating on Texas Instruments.
07/25/18
LOOP
07/25/18
NO CHANGE
Target $135
LOOP
Buy
Texas Instruments Q2 results and guidance were 'solid', says Loop Capital
Loop Capital analyst Cody Acree kept his Buy rating and $135 price target on Texas Instruments after its Q2 results that were in line with the recent positive pre-announcement and from other indications within the semiconductor industry. The analyst notes that the outperformance in the quarter was driven by consistent positive margin leverage and lower than expected operating expenses, along with "solid diversified guidance" and attractive order growth. Acree sees "broad" demand strength for TI products in the Industrial and Auto markets, which accounted for about 60% of total sales.
NXPI NXP Semiconductors
$93.13

-1.44 (-1.52%)

08/02/18
LEHM
08/02/18
INITIATION
Target $100
LEHM
Equal Weight
NXP Semiconductors reinstated with an Equal Weight at Barclays
Barclays analyst Blayne Curtis reinstated coverage of NXP Semiconductors with an Equal Weight rating and $100 price target. The analyst sees "too much uncertainty on the top and bottom line" for a more constructive rating at this time. He believes NXP shares will trade at a discount to "higher quality" analog peers.
08/02/18
08/02/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Magnolia Oil & Gas (MGY) initiated with a Buy at SunTrust. 2. VICI Properties (VICI) initiated with a Neutral at Citi. 3. Cision (CISN) initiated with a Buy at Citi. 4. Allena Pharmaceuticals (ALNA) initiated with a Buy at Ladenburg. 5. NXP Semiconductors (NXPI) reinstated with an Equal Weight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/30/18
NEED
07/30/18
NO CHANGE
Target $120
NEED
Strong Buy
NXP Semiconductors price target lowered to $120 from $130 at Needham
Needham analyst Rajvindra Gill lowered his price target on NXP Semiconductors (NXPI) to $120 to reflect last week's sell-off that followed its earnings, buyback, and terminated Qualcomm (QCOM) deal. The analyst also keeps his Strong Buy rating and believes that investors will re-evaluated the shares, given that the company's revenue mix is much healthier on combination of auto, industrial and internet of things end markets, while the revenues lost from ZTE (ZTCOY) component import ban should resume in Q3.
07/27/18
07/27/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. NXP Semiconductors (NXPI) reinstated with a Neutral at BofA/Merrill. 2. uniQure (QURE) initiated with an Overweight at Cantor Fitzgerald. 3. Autolus Therapeutics (AUTL) initiated with a Neutral at Goldman Sachs. 4. Pure Storage (PSTG) initiated with an Overweight at JPMorgan. 5. Plains All American (PAA) initiated with a Buy at Seaport Global. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
ADI Analog Devices
$95.13

0.18 (0.19%)

07/23/18
MSCO
07/23/18
NO CHANGE
MSCO
Tariff uncertainty a potential risk to semiconductor demand, says Morgan Stanley
Morgan Stanley analyst Joseph Moore said the firm's quarterly survey of distributors leads him to expect "solid" Q2 results and Q3 guidance from broad-based semiconductor companies this earnings season as demand remains strong. However, the present tariff related uncertainty present a risk for a "demand shock" that could lead to an inventory unwind in the semi supply chain, Moore warns investors. He thinks the potential of further semi stock outperformance is limited at this stage of the cycle, while "even the slightest whiff on the demand front" could lead to a significant decline in stocks, he tells investors. Moore added that he favors companies with more defensive characteristics, such as Analog Devices (ADI), over those with more commodity exposure and lower margins, like Cypress Semiconductor (CY). Other publicly traded companies in the semiconductors space include Micron (MU), AMD (AMD), Intel (INTC), Marvell (MRVL), Microchip (MCHP), Nvidia (NVDA), Qualcomm (QCOM) and Texas Instruments (TXN). Shares of Micron are down 2.5% in pre-market trading to $53.65.
07/19/18
NOMU
07/19/18
INITIATION
NOMU
Nomura rolls out Analog Semi coverage, names ON top pick
Nomura Instinet analyst Krysten Sciacca last night rolled out coverage on Analog Semiconductors. The analyst expects the group to outperform throughout the remainder of 2018 given its "steadier business models" versus other semi sectors, "strong" free cash flow generation and the "strong" demand coming from the auto and industrial applications. Her top pick is ON Semiconductor (ON), which the analyst initiated with a Buy rating and $30 price target. ON currently trades at a 35% discount to the Analog group, but its multiple should expand as investors come to better appreciate the company's exposure to industrial and auto, Sciacca told investors in a research note. She believes the company's 2020 target model will likely prove conservative. Sciacca also initiated coverage of Microchip (MCHP) with a Buy rating and $110 price target. The stock currently trades at a 22% discount to the comp group, but its "aggressive" de-leveraging, market share gains, and "strong" executional track record warrant the stock returning to its historical five-year average premium of 2%, the analyst contends. She initiated Cree (CREE) with a Hold rating and $44 price target saying the stock is already pricing in tailwinds and assumed coverage of Analog Devices (ADI) with a Neutral rating and $100 price target.
MXIM Maxim Integrated
$61.41

0.02 (0.03%)

07/27/18
MKMP
07/27/18
NO CHANGE
Target $62
MKMP
Neutral
Maxim Integrated price target raised to $62 from $56 at MKM Partners
MKM Partners analyst Ruben Roy raised his price target on Maxim Integrated to $62 after its Q4 earnings beat. The analyst notes that the 80bps gross margin expansion was generated by the company's focus on higher margin products, while the Auto, Industrial, and Data Center end markets drove its topline growth. Roy keeps his Neutral rating on Maxim Integrated, adding that its current valuation multiple of 18.9-times expected forward earnings is above the peer group average of 17.6-times.
07/27/18
SRCH
07/27/18
DOWNGRADE
SRCH
Hold
Maxim Integrated downgraded to Hold from Buy at Summit Insights
Summit Insights analyst Kinnagai Chan downgraded Maxim to Hold from Buy citing increased uncertainty in automotive and industrial end-markets.
07/17/18
SUSQ
07/17/18
NO CHANGE
SUSQ
Semi lead-times signal strong demand backdrop, says Susquehanna
Susquehanna analyst Christopher Rolland said his primary research reveals modestly expanding lead times for semis during Q2, suggesting a strong demand backdrop. He also suggested it could be due to some over-ordering and noted they are just below the 2011 peak. The analyst believes Q2 is likely to be solid for the group, but adds that over-ordering risks are growing.
06/21/18
LOOP
06/21/18
INITIATION
Target $70
LOOP
Buy
Maxim Integrated initiated with a Buy at Loop Capital
Loop Capital analyst Cody Acree initiated Maxim Integrated with a Buy rating and a price target of $70, saying the company presents an "increasingly compelling" restructuring story. Acree states that after returning to growth in 2017 following years of flat to declining sales, Maxim now offers a balanced revenue mix across multiple high-growth sub-segments of the chip industry amid rising demand for features and functionality. The analyst also points to the company's high operating efficiency, allowing Maxim to return more of its free cash flows to shareholders.
MPWR Monolithic Power
$139.83

0.22 (0.16%)

07/20/18
OPCO
07/20/18
NO CHANGE
Target $150
OPCO
Outperform
Oppenheimer remains a buyer of Monolithic Power ahead of Q2 results
Oppenheimer analyst Rick Schafer maintained an Outperform rating and $150 price target on Monolithic Power Systems ahead of the company's Q2 results on July 25. In a research note to investors, Schafer says he remains a buyer, as he sees a beat/raise set-up, and contends that the company has "myriad greenfield growth opportunities" in diverse end markets including auto, DC/cloud, motion control and ecommerce. Additionally, he says he likes management's history of consistent execution and long-term growth/GM story.
06/11/18
OPCO
06/11/18
NO CHANGE
Target $150
OPCO
Outperform
Monolithic Power price target raised to $150 from $130 at Oppenheimer
Oppenheimer analyst Rick Schafer raised his price target for Monolithic Power to $150 from $130 following the company's analyst day and after management raised Q2 outlook and detailed plan to achieve $1B revenues by 2021. With shares up 450% over past five years, the analyst believes investors underappreciate potential for growth acceleration and sees $2B top-line organically attainable within five to six years. He reiterates an Outperform rating on the shares.
06/05/18
DBAB
06/05/18
NO CHANGE
Target $140
DBAB
Buy
Monolithic Power price target raised to $140 from $130 at Deutsche Bank
Deutsche Bank analyst Ross Seymore raised his price target for Monolithic Power to $140 ahead of the company's analyst day on June 7. The analyst expects the quality of the company's growth to continue improving as it "further penetrates long-tailed end markets such as Server, Auto and Industrial." This combination of faster growth and rising quality should remain compelling to long-term investors, Seymore tells investors in a research note. He keeps a Buy rating on Monolithic Power.
05/18/18
COWN
05/18/18
INITIATION
Target $150
COWN
Outperform
Monolithic Power initiated with an Outperform, $150 price target at Cowen
As reported previously, Cowen analyst Matthew Ramsay initiated Monolithic Power with an Outperform rating. The analyst cited its upcoming product ramps, its recent growth rate and expectations for it to accelerate, which he believes will drive upward earnings revisions. Ramsay has a $150 price target on Monolithic Power shares.

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
09/26/18
09/26
10:16
09/26/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$151.89

2.98 (2.00%)

10:15
09/26/18
09/26
10:15
09/26/18
10:15
Hot Stocks
IBM rises after UBS says buy on AI potential, low public cloud exposure »

In a research note to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

10:15
09/26/18
09/26
10:15
09/26/18
10:15
General news
Breaking General news story  »

Week of 9/21 EIA…

SVMK

SurveyMonkey

$0.00

(0.00%)

10:13
09/26/18
09/26
10:13
09/26/18
10:13
Syndicate
SurveyMonkey indicated to open at $20, IPO priced at $12 »

SurveyMonkey (SVMK)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BBVA

Banco Bilbao

$6.55

-0.035 (-0.53%)

10:12
09/26/18
09/26
10:12
09/26/18
10:12
Hot Stocks
Banco Bilbao designates CEO Carlos Torres Vila as next chairman »

The board BBVA approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

F

Ford

$9.37

-0.025 (-0.27%)

, VLKAY

Volkswagen

$0.00

(0.00%)

10:10
09/26/18
09/26
10:10
09/26/18
10:10
Periodicals
Ford expands partnership talks with VW, Mahindra to cut costs, Reuters reports »

Ford (F) CEO Jim Hackett…

F

Ford

$9.37

-0.025 (-0.27%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 02

    Oct

SQ

Square

$94.76

-0.64 (-0.67%)

10:10
09/26/18
09/26
10:10
09/26/18
10:10
Options
Heavy trading in Square weekly options as shares fall from record highs »

Heavy trading in Square…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 26

    Nov

ETTX

Entasis Therapeutics

$0.00

(0.00%)

10:03
09/26/18
09/26
10:03
09/26/18
10:03
Syndicate
Entasis Therapeutics opens at $13.45, IPO priced at $15.00 per share »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WOR

Worthington

$42.88

-3.39 (-7.33%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Worthington falls -7.4% »

Worthington is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

GPRO

GoPro

$7.25

0.62 (9.35%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Options
Active trading in GoPro weekly options as shares spike »

Active trading in GoPro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATU

Actuant

$27.10

-2.65 (-8.91%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Actuant falls -7.9% »

Actuant is down -7.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

PES

Pioneer Energy

$3.13

-0.325 (-9.42%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Pioneer Energy falls -8.1% »

Pioneer Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BFR

BBVA Banco Frances

$12.83

0.63 (5.16%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
BBVA Banco Frances rises 5.4% »

BBVA Banco Frances is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRS

Irsa Inversiones y Representaciones SA

$18.00

1.18 (7.02%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Irsa Inversiones y Representaciones SA rises 7.3% »

Irsa Inversiones y…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBD

Care Concepts I, Inc.

$24.22

(0.00%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Care Concepts I, Inc. rises 6.6% »

Care Concepts I, Inc. is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$7.25

0.62 (9.35%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
GoPro rises following analyst upgrade on 'compelling' products »

Shares of GoPro (GPRO)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMNY

Helios and Matheson

$0.02

-0.0015 (-8.06%)

, AMC

AMC Entertainment

$20.05

0.175 (0.88%)

09:56
09/26/18
09/26
09:56
09/26/18
09:56
Hot Stocks
Helios and Matheson sinks as AMC's Stubs A-List surpasses 380,000 members »

Shares of MoviePass…

HMNY

Helios and Matheson

$0.02

-0.0015 (-8.06%)

AMC

AMC Entertainment

$20.05

0.175 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 13

    Nov

SCG

Scana

$36.25

0.96 (2.72%)

, ALXN

Alexion

$134.40

5.4 (4.19%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Options
Early notable gainers among liquid option names on September 26th »

Notable gainers among…

SCG

Scana

$36.25

0.96 (2.72%)

ALXN

Alexion

$134.40

5.4 (4.19%)

VIAB

Viacom

$33.80

1.32 (4.06%)

NLSN

Nielsen

$28.00

0.795 (2.92%)

GE

General Electric

$11.42

0.15 (1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 18

    Feb

ABBV

AbbVie

$94.50

0.72 (0.77%)

, VRTX

Vertex

$184.11

1.54 (0.84%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Xu,…

ABBV

AbbVie

$94.50

0.72 (0.77%)

VRTX

Vertex

$184.11

1.54 (0.84%)

ACER

Acer Therapeutics

$30.55

(0.00%)

BHVN

Biohaven Pharmaceutical

$37.47

(0.00%)

CELG

Celgene

$88.38

0.82 (0.94%)

EXEL

Exelixis

$17.38

0.19 (1.11%)

PTLA

Portola Pharmaceuticals

$28.27

0.57 (2.06%)

BMY

Bristol-Myers

$62.20

0.38 (0.61%)

BIIB

Biogen

$342.79

1.21 (0.35%)

AMGN

Amgen

$208.06

1.59 (0.77%)

BLUE

Bluebird Bio

$141.90

(0.00%)

ONCE

Spark Therapeutics

$57.63

0.07 (0.12%)

LOXO

Loxo Oncology

$164.55

-2.25 (-1.35%)

RCKT

Rocket Pharmaceuticals

$25.11

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 01

    Oct

  • 03

    Oct

  • 04

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 22

    Oct

  • 25

    Oct

  • 29

    Oct

  • 09

    Nov

  • 26

    Nov

  • 27

    Nov

  • 01

    Dec

  • 31

    Dec

  • 14

    Jan

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Subcommittee on…

KO

Coca-Cola

$45.79

0.105 (0.23%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
Senate Environment and Public Works Committee to hold a hearing »

The Committee holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

  • 30

    Oct

TWTR

Twitter

$28.85

-0.26 (-0.89%)

, T

AT&T

$33.80

0.04 (0.12%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
Senate Commerce, Science & Transportation Committee to hold a hearing »

The Committee holds a…

TWTR

Twitter

$28.85

-0.26 (-0.89%)

T

AT&T

$33.80

0.04 (0.12%)

GOOG

Alphabet

$1,180.39

-4.17 (-0.35%)

CHTR

Charter

$325.69

2.3 (0.71%)

AMZN

Amazon.com

$1,964.97

-9.53 (-0.48%)

AAPL

Apple

$221.94

-0.25 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 04

    Oct

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 07

    Nov

  • 12

    Nov

  • 03

    Mar

AVHI

A.V. Homes

$21.48

(0.00%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
A.V. Homes to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 15

    Nov

PFE

Pfizer

$44.07

0.27 (0.62%)

, AMGN

Amgen

$208.06

1.59 (0.77%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
Drug Information Association to hold a virtual conference »

Biosimilar Reimbursement…

PFE

Pfizer

$44.07

0.27 (0.62%)

AMGN

Amgen

$208.06

1.59 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 01

    Oct

  • 03

    Oct

  • 03

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 30

    Oct

  • 09

    Nov

PTE

PolarityTE

$20.11

-1 (-4.74%)

, COOL

Ticker changed to PTE

$0.00

(0.00%)

09:53
09/26/18
09/26
09:53
09/26/18
09:53
Periodicals
Violations found by FDA at PolarityTE facility, Capitol Forum says »

The FDA send a Form 483…

PTE

PolarityTE

$20.11

-1 (-4.74%)

COOL

Ticker changed to PTE

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.